<DOC>
	<DOCNO>NCT02242071</DOCNO>
	<brief_summary>The effect autologous bone marrow mononuclear cell Motor Neuron Disease/Amyotrophic Lateral Sclerosis patient .</brief_summary>
	<brief_title>Cell Therapy Motor Neuron Disease/Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients diagnosis definite Motor Neuron Disease/amyotrophic lateral sclerosis . Age 1880 year HIV/HBV/HCV Malignancies Bleeding tendency Pneumonia Renal failure Severe liver dysfunction Severe anemia [ hb &lt; 8 ] Any bone marrow disorder Space occupy lesion brain Pregnancy lactation Other acute medical conditions/infections respiratory infection pyrexia leave ventricular ejection fraction &lt; 25 % Patient artificial ventilatory support</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Autologous Mononuclear Cell therapy</keyword>
	<keyword>Stem cell</keyword>
</DOC>